T3	Effect 0 116	Well-differentiated endometrial adenocarcinoma of the secretory type (FIGO Grade 1) with minimal myometrial invasion
T5	Subject 129 153	a postmenopausal patient
T6	Treatment 157 221	tamoxifen therapy 5 years after mastectomy for breast carcinoma.
T8	Sub-Disorder 131 145	postmenopausal
T9	Drug 157 166	tamoxifen
T10	Treat-Disorder 204 220	breast carcinoma
T4	Adverse_event 117 125	occurred
E1	Adverse_event:T4 
